| Literature DB >> 31582210 |
Nobuaki Higashi1, Rino Maeda2, Nakaba Sesoko2, Momoko Isono2, Sodai Ishikawa2, Yurina Tani2, Katsuhiko Takahashi2, Teruaki Oku3, Kyohei Higashi4, Shoichi Onishi4, Motowo Nakajima5, Tatsuro Irimura6.
Abstract
We examined whether chondroitin sulfates (CSs) exert inhibitory effects on heparanase (Hpse), the sole endoglycosidase that cleaves heparan sulfate (HS) and heparin, which also stimulates chemokine production. Hpse-mediated degradation of HS was suppressed in the presence of glycosaminoglycans derived from a squid cartilage and mouse bone marrow-derived mast cells, including the E unit of CS. Pretreatment of the chondroitin sulfate E (CS-E) with chondroitinase ABC abolished the inhibitory effect. Recombinant proteins that mimic pro-form and mature-form Hpse bound to the immobilized CS-E. Cellular responses as a result of Hpse-mediated binding, namely, uptake of Hpse by mast cells and Hpse-induced release of chemokine CCL2 from colon carcinoma cells, were also blocked by the CS-E. CS-E may regulate endogenous Hpse-mediated cellular functions by inhibiting enzymatic activity and binding to the cell surface.Entities:
Keywords: Chemokine; Chondroitin sulfate; Colon carcinoma; Heparan sulfate; Heparanase; Mast cell
Year: 2019 PMID: 31582210 DOI: 10.1016/j.bbrc.2019.09.126
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575